Table 2.
Disease | MicroRNA | Source (type of MSCs) | Target | Function | Model (In vitro, in vivo, human) | Ref |
---|---|---|---|---|---|---|
Intervertebral disc degeneration | miR-21 | Human bone marrow | TNF-α | Apoptosis | In vivo, Rat | [122] |
Stroke | miR-133b | Rat bone marrow |
b-III-tubulin (TuJ1), phosphorylated NF-H RhoA |
Cell shape, polarity and locomotion | In vivo, Rat | [123] |
Stroke | miR-17-92 cluster | Rat bone marrow | PTEN | Tumor suppression | In vivo, Rat | [125] |
Stroke | miR-133b | Rat bone marrow | Connective tissue growth factor and RhoA | Cell adhesion & migration. GTPase, actin stress | In vivo, Rat | [126] |
Breast cancer and Osteosarcoma | miR-21 andmiR-34a | Human bone marrow | – | Increased angiogenesis & tumor growth | In-vivo, mice | [82] |
Breast cancer | miR-23b | Human bone marrow | MARCKS | Cell cycling and motility | In vitro | [130] |
Breast cancer | miR-100 | Human bone marrow | Vascular endothelial growth factor (VEGF) | Angiogenesis | In vitro | [131] |
Glioblastoma | miR-146b | Rat | EGFR | Cell proliferation and cell survival. | In vivo, Rat | [132] |
Glioma | miR-584-5p | Human | CYP2J2 | Arachidonic acid and drug metabolism | In vivo, Mice | [92] |
Ischemia/reperfusion injury (IRI) -induced AKI | miR-15a, miR-15b and miR-16 | Human umbilical cord | CX3CL1 | Function as chemokine ligand | In vivo, Rat | [141] |
Ischemia/reperfusion injury (IRI) -induced AKI | miR-30 | Human WJMSCs | DRP1 | Mitochondrial and peroxisomal division | In vivo, Rat | [142] |
Kidney fibrosis and injery | miR-let7 | Human Bone marrow | TGF-β receptor 1 | Cell proliferation and apoptosis control | In vivo, Mice | [143] |
Myocardial infarction | miR29, miR24miR34, miR130, miR378 | Rat Bone marrow | PI3k-Akt and mTOR pathways | Cell cycle, proliferation and differentiation | In vivo, Rat | [144] |
Myocardial infarction | miR-22 | Ischemic Preconditioned Mice bone marrow | Mecp2, methyl CpG binding protein 2 | Apoptosis | In vivo, mice | [148] |
Myocardial infarction | miR-19a | Rat Bone marrow | PTEN | Tumor suppression, | In vivo, Rat | [149] |
Myocardial infarction | miR-132 | Mice bone marrow | RASA1 | Cell proliferation and growth | In vivo, mice | [40] |
Liver fibrosis | miR-181-5p | Mice adipose | Bcl2 and stat3 | Apoptosis and autophagy | In vivo, mice | [151] |
Hepatocellular carcinoma | miR-122 | Human adipose | Cyclin G1 and IGF 1R | Cell cycle and growth | In vitro, and In vivo, mice | [152] |
Autoimmune hepatitis | miR-223 | Mice bone marrow | NLRP3 | Cryopyrin production | In vivo, mice | [137] |
Liver fibrosis | miR-122 | Mice and human bone marrow | Cyclin G1, IGF 1R and P4HA1 | Cell cycle and proliferation Collagen and related protein synthesis | In vitro, and In vivo, mice | [153] |
Cardiotoxin-induced muscle injury | miR-494 | Human bone marrow | – | Induce muscle regeneration via increased angiogenesis and myogenesis | In vivo, In vitro | [87] |
Middle cerebral artery occlusion | miR-133b | Rat bone marrow | – | Modulate neurite outgrowth | In vivo, In vitro | [113] |
Osteoarthritis | miR-92a-3p | MSCs | WNT5A | Enhanced production of cartilage and homeostasis | In vivo | [158] |
Osteoarthritis | miR-320c | hBMSCs | MMP13 | – | In vivo | [159] |
Osteoarthritis | miR-140-5p | SMSC | Enhanced proliferation and migration of articular chondrocytes | In vitro | [160] |